Anal Cancer Flashcards

1
Q

Anal Cancer

In general, what is the standard treatment for anal canal squamous cell cancers?

A

concurrent chemoradiation (5-FU + MMC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anal Cancer

Which is/are TRUE regarding anal canal anatomy?

I. The anal canal is 7 to 8 cm in length.

II. The posterior wall of the anal canal is longer than the anterior.

III. The canal ends superiorly at the palpable upper border of the anal sphincter and puborectalis muscle of the anorectal ring.

IV. The distal end at the anal
verge is the level at which the walls of the anal canal come in contact in their normal resting state; it approximates the palpable groove between the lower edge
of the external sphincter and the subcutaneous part of the anal verge and
the junction with true skin.

A

II and III.
***

I. 3-4
II. lower edge of internal sphincter and the subcutaneous part of the external sphincter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anal Cancer

Perianal carcinomas are arbitrarily
considered to be cancers arising from the skin within a ___-cm radius of the anal
verge.

A

5 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anal Cancer

Which is FALSE regarding anal canal histology?

I. The perianal skin is similar to hair-bearing skin elsewhere.

II. At the anal verge, the skin
blends with a pale-colored zone, sometimes called the pecten, lined by modified cuboidal epithelium that lacks hair or glandular structures. This zone merges just below the dentate or pectinate line, which marks the mucosal folds
of the anal valves, with a transitional epithelium that incorporates features of
rectal, urothelial, and squamous epithelium.

III. The purplish red–colored
transitional zone extends proximally for about 2 cm until the pinker glandular mucosa of the rectum becomes dominant.

A

II.

pecten is lined by modified squamous epithelium (not cuboidal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anal Cancer

Lymphatic drainage of the perianal skin, anal verge, and canal distal to the dentate line.

A

superficial inguinal

with communication to the femoral and external iliac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anal Cancer

Lymphatic drainage of the anal canal around and above the dentate line?

A

internal pudendal
hypogastric
obturator nodes

(internal iliac system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anal Cancer

Lymphatic drainage of the proximal anal canal?

A

perirectal
superior hemorrhoidal nodes

(inferior mesenteric system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anal Cancer

Nerve supply of the smooth muscles of the internal sphincter

A

sympathetic fibers of S2-4 and hypogastric plexus

Anorectal continence is mediated by both cerebrospinal nerves and the
autonomic system. The smooth muscle of the internal sphincter is supplied by
parasympathetic fibers from the second, third, and fourth sacral segments as well
as sympathetic fibers from the hypogastric plexus. The upper canal has selective
sensitivity for intraluminal differences in pressure, and the autonomic nerves
mediate both the inhibitor and facilitator reflexes of the internal sphincter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anal Cancer

Nerve supply of the striated muscles of the external sphincter

A

internal rectal nerve, (a branch of the pudendal nerve arising from S2-4).
***
The
striated muscle of the external sphincter is under voluntary control and
innervated by the internal rectal nerve, a branch of the pudendal nerve arising
from the second, third, and fourth sacral nerves. The internal rectal nerve also
transmits pain, touch, and other sensations from the anal lining below the dentate
line and from the perianal skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anal Cancer

What is the most common histologic classification of anal cancers?

A

SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anal Cancer

Adenocarcinomas from the rectal-type mucosa in
the upper canal are classified as primary anal cancers, as long as they are within the anatomic boundaries of the anal canal.

TRUE or FALSE

A

FALSE.

Adenocarcinomas from the rectal-type mucosa in
the upper canal are classified as primary rectal cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anal Cancer

What HPV subtype/s is/are most commonly associated with the development of anal cancer?

A

HPV-16.

Subtypes of HPV with a high risk of association with cancer are type 16 in particular and, to a lesser extent, types 18, 31, 33, 35, and others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anal Cancer

In general, what are the risk factors for developing anal cancer?

A

sexually transmissible viruses (HPV)
,
immunosuppression (HIV and transplant, etc),

tobacco smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anal Cancer

Anal cancer is considered an AIDS-defining illness.

TRUE or FALSE?

A

False.
***
However, although anal cancer has not been designated an acquired immunodeficiency
syndrome (AIDS)-defining condition, data from the U.S. AIDS Cancer Registry
linkage study showed that the rate of HPV-associated cancers and precursors was
increased in HIV-infected persons for all anogenital sites compared with the
general population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anal Cancer

HAART introduction decreased the rates of anal cancer development in HIV-infected individuals.

TRUE or FALSE?

A

FALSE.
***
Although there was a
decrease in the incidence of Kaposi sarcoma and lymphoma by a few years after HAART became available, at the time of the review, there had been no
significant reduction in the incidence of less common malignancies such as
anogenital cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anal Cancer

Benign conditions causing chronic and constant inflammation of the anal mucosa such as fistulae, fissures, and hemorrhoids are considered as risks factors predisposing to anal cancer.

TRUE or FALSE?

A

Benign conditions such as fistulae, fissures, and hemorrhoids do not appear to predispose to cancer.

Chronic anal inflammation due to inflammatory bowel disease has also been discounted as a risk factor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anal Cancer

Which is/are TRUE regarding AIN?

I. Most squamous cell cancers of the anal region, especially the canal, are believed
to be preceded by high-grade AIN.

II. It has been estimated that no more
than 1% of cases with AIN develop invasive cancer per year.

III. Anal dysplasia recurs
frequently despite excision, laser ablation, or topical therapies.

none
I only
II only
III only
I & II only
I & III only
II & III only
A

All.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anal Cancer

What are the two most common mechanism of spread in anal cancers?

A

direct extension

lymphatic extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anal Cancer

Anal cancer invades the prostate gland more commonly than the vaginal septum.

TRUE or FALSE?

A

False.
***
Invasion of the vaginal septum and vaginal mucosa is more common than
invasion of the prostate gland, but anovaginal fistulas occur in fewer than 5% of
women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anal Cancer

What is the most common pattern of relapse?

A

locoregional failure (in the area of the primary tumor and lymph nodes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anal Cancer

Perianal cancers tend to grow locally and may extend into the anal canal.
When the site of origin is in doubt, it is conventional to classify the cancer as
arising in the anal canal.

TRUE or FALSE?

A

True.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Anal Cancer

Where is the most common site of metastasis in perianal cancers?

A

ipsilateral inguinal nodes.
***
The ipsilateral inguinal nodes are the most common site
of metastasis and are involved in from 5% to 20% of cases. Extrapelvic
metastases are uncommon except in locally advanced cancer or those with nodal
metastases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Anal Cancer

What is the most common presenting symptoms?

A

Bleeding and anal discomfort are the most common symptoms and are reported by about half the patients.
Less common complaints include awareness of an anal mass, pruritus, and anal discharge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Anal Cancer

What imaging modality is considered the most accurate method for assessing the primary cancer “including” the pelvic nodes.

A

MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Anal Cancer

Anal Canal TNM staging
Identify the T-stage:

Tumor less than 2 cm but with invasion to vagina, urethra, bladder

A

T4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Anal Cancer

Anal Canal TNM staging
Identify the T-stage:

Tumor less than 2 cm but with invasion to rectal wall, perirectal skim, subcutaneous tissue, or sphincter muscle.

A

T1
***

T1 is 2 cm or less.
(invasion
of the rectal wall, perirectal skin, subcutaneous tissue, or sphincter muscle is not
included as T4).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Anal Cancer

Anal Canal TNM staging
Identify the T-stage:

Bowen disease

A

Tis
***
High-grade squamous intraepithelial lesion (previously termed carcinoma in situ, Bowen disease, AIN II–III, high-grade AIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Anal Cancer

Anal Canal TNM staging
Identify the T-stage:

3 cm

A
T2
***
>2 cm but ≤5 cm
***
>5 cm is T3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Anal Cancer

Anal Canal TNM staging
Identify the N-stage:

+ inguinal nodes

A

N1a
***
inguinal, mesorectal, or internal iliac

30
Q

Anal Cancer

Anal Canal TNM staging
Identify the N-stage:

+ external iliac and internal iliac nodes.

A

N1c
***
external iliac alone is N1b

31
Q

Anal Cancer

Anal Canal TNM staging
Identify the stage group:

T2-3 N0 M0

A

Stage II

32
Q

Anal Cancer

Anal Canal TNM staging
Identify the stage group:

T2 N1 M0

A

Stage IIIA

33
Q

Anal Cancer

Anal Canal TNM staging
Identify the stage group:

T4 N0 M0

A

Stage IIIB

34
Q

Anal Cancer

Anal Canal TNM staging
Identify the stage group:

T3 N1 M0

A

Stage IIIC

35
Q

Anal Cancer

Perianal Canal TNM staging

T1-3 is similar to anal canal staging.
What constitutes T4?

A

invasion of deep extradermal structures (i.e., cartilage, skeletal muscle, or bone)

36
Q

Anal Cancer

Perinal Canal TNM staging
Identify the earliest stage group:

N1

A

Stage III

37
Q

Anal Cancer

Anal Canal TNM staging
Identify the stage group:

T4 N0 M0

A

Stage III

38
Q

Anal Cancer

Prognostic Factors:
What tumor factor is the most useful predictor for local control, preservation of anorectal function, and survival?

A

tumor size

39
Q

Anal Cancer

Prognostic Factors:

Involvement of regional
lymph nodes is an adverse factor for survival and control
of the primary tumor.

TRUE or FALSE?

A
False.
***
Involvement of regional
lymph nodes is an adverse factor for survival but, in most series, not for control
of the primary tumor
40
Q

Anal Cancer

Prognostic Factors:

HPV-positive anal squamous cell carcinoma confer an overall survival advantage over HPV-negative anal cancer patients.

TRUE or FALSE?

A

True.

41
Q

Anal Cancer

What are the two groups that reported on studies that established RT +5FU +MMC as the standard first-line treatment in anal cancers?

A

UKCCCR (ACT I)

EORTC

42
Q

Anal Cancer

What is the initial RT prescription in the UKCCCR ACT I and EORTC studies that established RT +5FU +MMC as the standard first-line treatment in anal cancers?

A

UKCCCR = 45 Gy in 20 to 25fx

EORTC = 45 Gy/25fx

43
Q

Anal Cancer

When is a boost dose given in the UKCCCR ACT I and EORTC studies that established RT +5FU +MMC as the standard first-line treatment in anal cancers?

What are the criteria/modality/and doses?

A

after 6 weeks (both)

UKCCCR:
( <50% regression, 15Gy/6fx EBRT or perineal field, or 25Gy/2-3 days by 192-I implant)

EORTC:
complete response - 15 Gy
partial response - 20 Gy
EBRT or interstitial radiation

44
Q

Anal Cancer

UKCCCR and EORTC.

In the UKCCCR study (3y), local control, colostomy-free survival, were significantly improved.
OS was not.

In the EORTC study (5y), locoregional recurrence rate was significantly decreased.
OS was not.

Which study showed a significant OS difference favoring CRT after a median of 13y follow-up?

A

UKCCCR’s

45
Q

Anal Cancer

What is a problematic complication of treatment with MMC?

A

hematologic tocxicity.

46
Q

Anal Cancer

What studies were done to determine if MMC is a necessary component of treatment by comparing RT with FU only and FU+MMC?

A

RTOG 8704
ECOG 1289

no significant OS difference, but significantly decreased rates of local failure and colostomy.

47
Q

Anal Cancer

What is the RT dose used in RTOG 8704 and
ECOG 1289?

A

45 to 50.4 in 25 to 28 fractions.

boost of 9 Gy/1.8/5 after positive biopsy (6 weeks after)

48
Q

Anal Cancer

What study substituted CDDP for MMC in the treatment regimen, which initially showed no differences in DFS and OS, a higher colostomy rate for CDDP, and a significantly increased OS and DFS rates favoring the regimen with MMC after 5-years.

A

RTOG 9811

49
Q

Anal Cancer

What is the RT dose used in RTOG 9811

A
59 Gy
(45/1.8/25)+(14/2/7) uninterrupted
50
Q

Anal Cancer

What is the management for residual or recurrent cancer at the primary site?

What is the salvage for inguinal nodal metastases?

A

APR or multivisceral pelvic resection.

inguinofemoral lymphadenectomy.

51
Q

Anal Cancer

What is the principal treatment for AIN?

A

Surgery

52
Q

Anal Cancer

Eradication of cancer by RT, with or without chemotherapy in patients presenting with incontinence for solid stools restore continence in such patient.

TRUE or FALSE?

A

False.
***
Eradication of cancer by RT, with or without
chemotherapy, does not restore continence in such patients, likely because the
cancer is replaced by fibrous tissue rather than the specialized muscle of the anal
sphincters.

53
Q

Anal Cancer

What are the possible surgical approaches in patients with incontincene?

A

colostomy –> preop RT + chemo –> immediate or delayed resection

or

APR –> CCRT

54
Q

Anal Cancer

What subsets of patients with invasive cancer can be treated with definitive local excision alone (assuming a negative margin excision)

A

ALL of the ff:

small <2cm
well-differentiated
no sphincter invasion
distal to the dentate line.

Local excision of small cancers of the distal canal or perianal skin is
generally more expedient and associated with less morbidity than radiationbased
treatments. However, if resection margins are positive or considered
inadequate, and further local excision is not possible, the patient should receive
chemoradiation or RT alone.

55
Q

Anal Cancer

In general, what is the standard treatment for perianal canal squamous cell cancers?

A

Wide local excision with a 1-cm margin
(provided that anal continence can be preserved)
(this is true regardless of histologic type)

or

CCRT regimen same as anal canal treatment
+/- inguinal nodal irradiation

56
Q

Anal Cancer

In general, what is the standard treatment for perianal canal basal cell cancers?

A

Same as SKIN.
***
The principles of management for the uncommon basal cell and adenocarcinomas of the perianal skin are similar to those for these histologic types elsewhere on the skin.

57
Q

Anal Cancer

In HIV-infected patients, what are the two factors that may predict for heightened acute normal tissue toxicity or poor cancer control?

A

CD4 count <200/μL at the start of treatment

or the presence of AIDS

58
Q

Anal Cancer

In planning the radiation treatment for HIV-infected patients, a reduced-dose (30 Gy) is necessary to avoid the increased normal tissue toxicity found in this group of patients.

TRUE or FALSE?

A

False.
***
This is historical.

Most recent reports indicate that it is not necessary to electively modify standard
protocols of RT (with respect to dose, fractionation, or volume) and
chemotherapy (either 5-FU and MMC or 5-FU and CDDP), but modifications
should be based on the severity of side effects in each individual patient

Therefore, dose-reduction not reduced-dose.

59
Q

Anal Cancer

What is the preferred management for adenocarcinomas involving the anal canal arising from rectal-type mucosa that extends below the upper muscular boundary of the canal?

A

treated similarly with rectum

60
Q

Anal Cancer

What is the usual upper border if the lumbosarcral junction border has been reduced after 30.6 Gy to reduce radiation enteritis?

What nodal group/s is/are removed from and retained within the field?

A

lower end of SIJ

removed: common iliac, upper presacral

retained:
perirectal, lower presacral and internal iliac (+/- external iliac)

61
Q

Anal Cancer

After 45 Gy, a further field reduction was made.
What is the purpose?

A

boost the primary tumor

62
Q

Anal Cancer

After 45 Gy, a further field reduction was made to boost the primary tumor.

What is the typical dose?

A

to reach 54/30 or 59.4/33

boost dose of 9/1.8/5 or 14/1.8/8

63
Q

Anal Cancer

What is the usual lower border of a conventional RT field?

A

3-cm below the most inferior extent of the primary tumor

64
Q

Anal Cancer

If RT is given as a single-modality treatment, what should be the dose to the primary tumor?

A

A dose to the primary tumor of 60 to 65 Gy over 6 to 7 weeks, in 1.8- to 2-Gy fractions, is commonly prescribed

65
Q

Anal Cancer

Prolonged OTT is significantly associated with worse:
I. OS
II. LC
III. Colostomy free survival

A. None
B. All
C. I only
D. II only
E. III only
F. I & II only
G. III & II only
H. I & III only
A

D. II only.
Local control.

Analysis of
two RTOG trials showed a trend toward an association between longer OTT
and colostomy failure and a statistically significant association with local failure.
RTT and OTT were not correlated with overall or colostomy-free survival
rates.

66
Q

Anal Cancer

What is the usual RT dose if small (<4 cm) perianal cancers with low risk of regional node metastases are treated by radiation?

A

If small (<4 cm) perianal cancers with low risk of regional node metastases are treated by radiation, a dose of 60 to 66 Gy in 2-Gy fractions over 6 weeks may be used.

67
Q

Anal Cancer
(from in-service bank)

  1. For Questions 38-40: A 45 year old male (known HIV) has a 6 month history of anal pain. There was a palpable 3cm rectal mass extending to the anorectal ring with fluctuant left sided gluteal mass and a 2cm palpable left inguinal lymph node upon consult. Patient was referred to a general surgeon, and a biopsy of the mass under anesthesia was done which resulted to Squamous Cell Carcinoma. The attending physician called for a multidisciplinary meeting and as a member, you suggested further work-up and management that would be done to the patient. Which of the following statements might NOT be appropriate for this case?
    A. Ask for a consent for HIV antibody status and CD4 count
    B. Pelvic MRI with contrast
    C. Thoracic and Upper Abdominal CT Scan, or PET-CT Scan
    D. Wide excision of the mass
A

D

68
Q

Anal Cancer
(from in-service bank)

  1. Further work-up showed an anal mass to be 4cm in size infiltrating the external and internal sphincter, with contrast enhancement of enlarged left mesorectal, internal iliac and inguinal lymph nodes on pelvic MRI with IV contrast. No evidence of distant metastasis. Patient is HIV positive with a CD4 count of 70. What would be the initial recommendation for this patient?
    A. Refer patient to Infectious Disease specialist to start patient on highly active antiretroviral therapy if it will not delay definitive treatment.
    B. Do outright abdominoperineal resection only.
    C. Do outright abdominal resection with inguinal lymph node dissection.
    D. Administer concurrent chemoradiation.
A

A

69
Q

Anal Cancer
(from in-service bank)

  1. What could possibly be the best choice of treatment regimen could you possible consider if CD4 count is persistently <200?
    A. Concurrent chemoradiotherapy with 5-FU with Mitomycin C + RT
    B. Concurrent chemoradiation with 5-FU with CDDP + RT
    C. Radiation therapy followed by abdominoperineal resection
    D. Abdominoperineal resection with inguinal lymphadenectomy
A

B

70
Q

Anal Cancer
(from in-service bank)

  1. For Questions 41–43: A 65 year old female has presented with perianal discomfort and itching for several weeks. Patient consulted a colorectal surgeon, who appreciated a 1-2cm anal mass. She then undergone anoscopy and biopsy which revealed squamous cell carcinoma arising from high grade intraepithelial lesion, HPV positive, P16 positive. Complete metastatic work-up showed no extrapelvic metastasis, Pelvic MRI with IV contrast showed 2.5 cm focus of restricted diffusion along the anal canal likely correlating to the known malignancy. This was consistent with PET positive focal uptake at the anus (SUV 6.5) with no evidence of lymph node metastasis. Which statement is TRUE about tumor prognostic factors in anal cancers?
    A. Regardless of the HPV status, p16 positive anal squamous cell cancer have good prognosis.
    B. When confined to the pelvis, lymph node status is the most useful predictor for local control.
    C. Most adverse factor for survival is the presence of extrapelvic metastasis.
    D. Lymph node status is an adverse factor for survival and local control of primary tumor.
A

C

71
Q

Anal Cancer
(from in-service bank)

  1. If this patient turns out to be HIV negative, what will be your proposed management for this patient?
    A. Concurrent chemotherapy with 5-FU with Mitomycin C + RT
    B. Concurrent chemoradiation with 5-FU with CDDP + RT
    C. Radiation therapy followed by abdominoperineal resection
    D. Abdominoperineal resection with inguinal lymphadenopathy
A

A

72
Q

Anal Cancer
(from in-service bank)

  1. In relation to your answer from the previous item, following statements are true, EXCEPT:
    A. Accurate target delineation should be done for adequate coverage of elective inguinal node irradiation
    B. Maintenance chemotherapy decreases the rate of disease recurrence following primary treatment
    C. Giving a higher RT dose does not improve local control nor tumor free survival.
    D. Role of surgery for this case is reserved for persistent or recurrent disease
A

B